This Fund Sold $49.5 Million of Gildan as the Apparel Maker Pursues $2.2 Billion HanesBrands Merger

Coliseum Capital fully exited its ~1.0 million‑share stake in Gildan Activewear in Q3, a reduction valued at roughly $49.5 million based on quarterly average prices, per an SEC filing. Gildan shares trade around $55.82 (market cap ~$8.3bn) with TTM revenue of $3.4bn and net income of $475.1m; management reaffirmed 2025 guidance and reported a record adjusted operating margin of 23%. The divestment comes as Gildan pursues a $2.2bn acquisition of HanesBrands—promised to roughly double revenue and deliver ~$200m in annual synergies—raising questions about integration risk that may have influenced the portfolio reweighting.

Analysis

Market structure: Coliseum’s wholesale exit from GIL is a liquid repositioning, not proof of fundamental deterioration, but it highlights investor concern over integration risk from the $2.2bn HanesBrands deal. If synergies ($200m/year target) are delivered within 24–36 months, the combined entity should gain purchasing scale and lower blended COGS by an estimated 150–250bps, pressuring smaller private-label suppliers and improving gross margin leverage for GIL/HBI buyers.

Risk assessment: Tail risks include a botched integration (1–5% probability) that destroys >$0.5bn of value via supply-chain disruption or realized synergies falling <50%, and credit risk if net leverage rises >3.0x EBITDA triggering covenant stress within 12–18 months. Near-term (days/weeks) volatility will be driven by financing disclosures and shareholder vote timing; medium-term (3–12 months) by Q4 guidance and initial synergy realization; long-term (2–3 years) by actual run-rate of the $200m savings.

Trade implications: Favor tactical exposure to GIL’s optionality but hedge execution risk: a small core long with downside protection is preferable to naked exposure. Cross-asset: watch cotton/freight — a sustained >8% move in cotton futures materially alters margin prospects and should trigger rebalancing between apparel equities and commodity plays.

Contrarian angles: The market may underprice successful scale benefits — if GIL can convert 50% of synergies to EBIT within 18 months, a 25–40% equity rerating is plausible; conversely, consensus overlooks integration cadence and cash-tax/shock effects. Historical parallel: VF/Smartwool-style integrations show early margin drag then step-up in year 2–3, so size positions to survive 12–24 months of noise.

Key Decisions for Investors

• Consider establishing a 2–3% portfolio long position in GIL at or below $58 (current $55.82) with a 18–24 month target price of $75 (≈30% upside if synergies realized); place a hard stop at $50 (≈10% below current) and buy 12-month 45-strike puts (≈20% OTM) or implement a 1:1 collar by selling 9-month 65 calls to finance protection.
• Avoid outright long HBI equity pre-close; instead, express event risk with a 3–6 month HBI spread: buy a 3–6 month 20% OTM put if preliminary regulatory/financing filings show dilution risk, or purchase a 3–6 month 10%/20% call spread to capture deal completion upside while capping cost.
• If cotton futures (ICE) decline more than 8% vs the 3-month moving average, rotate 1–2% portfolio from small apparel names into GIL to capture margin tailwind; conversely, if cotton rises >12%, reduce GIL exposure by 50% and favor apparel companies with pass-through pricing power.
• Monitor GIL credit spreads and CDS: if 5-year CDS widens above 150bps (or corporate bonds yield >5.5%) buy 1–2% notional of GIL senior unsecured bonds as a yield play with expected recovery upside; exit if leverage surpasses 3.0x EBITDA on next 10-Q or synergies revision falls >30%.